Literature DB >> 4148969

Albumin transcapillary escape rate and plasma volume during long-term beta-adrenergic blockade in essential hypertension.

H H Parving, F Gyntelberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4148969     DOI: 10.3109/00365517309084336

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


× No keyword cloud information.
  6 in total

1.  Metabolic effects of beta-adrenoreceptor blockers.

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 2.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

3.  [The importance of changes in whole-body balance of sodium and noradrenaline in essential hypertension (author's transl)].

Authors:  R Lang; A Maxrath; U Laaser; K A Meurer; W Kaufmann
Journal:  Klin Wochenschr       Date:  1978-11-15

4.  Autonomic neuropathy predisposes to rosiglitazone-induced vascular leakage in insulin-treated patients with type 2 diabetes: a randomised, controlled trial on thiazolidinedione-induced vascular leakage.

Authors:  A J Rennings; P Smits; M W Stewart; C J Tack
Journal:  Diabetologia       Date:  2010-05-25       Impact factor: 10.122

5.  Reduced transcapillary escape of albumin during acute blood pressure-lowering in type 1 (insulin-dependent) diabetic patients with nephropathy.

Authors:  H H Parving; J Kastrup; U M Smidt
Journal:  Diabetologia       Date:  1985-11       Impact factor: 10.122

6.  Pharmacokinetics and Pharmacodynamics of T-Cell Bispecifics in the Tumour Interstitial Fluid.

Authors:  Miro Julian Eigenmann; Tine Veronica Karlsen; Marek Wagner; Olav Tenstad; Tina Weinzierl; Tanja Fauti; Hans Peter Grimm; Trude Skogstrand; Christian Klein; Johannes Sam; Pablo Umana; Marina Bacac; Helge Wiig; Antje-Christine Walz
Journal:  Pharmaceutics       Date:  2021-12-07       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.